Literature DB >> 22083546

Involvement of calcium-sensing receptor in oxLDL-induced MMP-2 production in vascular smooth muscle cells via PI3K/Akt pathway.

Hong-Xia Li1, Fan-Juan Kong, Shu-Zhi Bai, Wen He, Wen-Jing Xing, Yu-Hui Xi, Guang-Wei Li, Jin Guo, Hong-Zhu Li, Ling-Yun Wu, Rui Wang, Guang-Dong Yang, Ye Tian, Chang-Qing Xu.   

Abstract

Matrix metalloproteinase-2 (MMP-2) is constitutively expressed in vascular smooth muscle cells (VSMCs) and up-regulated in atherosclerotic lesion by various stimuli, such as oxidized low-density lipoprotein (oxLDL). Calcium-sensing receptor (CaSR) is also expressed in VSMCs, but it remains unclear whether CaSR is associated with overproduction of MMP-2 in VSMCs. In this study, the expression of MMP-2 was detected by real-time PCR and Western blot analysis, and the gelatinolytic activity of MMP-2 was measured using gelatin zymography. Our results showed that oxLDL enhanced MMP-2 expression and activity in rat aortic VSMCs in a time- and dose-dependent manner. In addition, CaSR expression was up-regulated by oxLDL. Manipulating CaSR function in these cells by NPS2390 (an antagonist of CaSR) or GdCl(3) (an agonist of CaSR) affected the oxLDL-induced MMP-2 production. In VSMCs, oxLDL stimulated the rapid activation of phosphatidylinositol 3-kinase (PI3K)/Akt signal pathway, as determined by Western blot analysis. Phosphorylation of Akt and MMP-2 production stimulated by oxLDL were attenuated by LY294002 (a specific inhibitor of PI3K). Activation of Akt was suppressed by NPS2390 but enhanced by GdCl(3). In contrast, oxLDL had no stimulatory effect on the phosphorylation of JNK, and pretreatment with SP600125 (an inhibitor of JNK) produced no significant effect on oxLDL-induced MMP-2 production. These results suggest that CaSR mediates oxLDL-induced MMP-2 production in VSMCs via PI3K/Akt signal pathway.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22083546     DOI: 10.1007/s11010-011-1133-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

Review 1.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

Review 2.  Role of oxidized low density lipoprotein in atherogenesis.

Authors:  J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

Review 3.  Expression and role of the calcium-sensing receptor in the blood vessel wall.

Authors:  Guerman Molostvov; Rosemary Bland; Daniel Zehnder
Journal:  Curr Pharm Biotechnol       Date:  2009-04       Impact factor: 2.837

4.  High-density lipoproteins prevent the oxidized low-density lipoprotein-induced epidermal [corrected] growth factor receptor activation and subsequent matrix metalloproteinase-2 upregulation.

Authors:  Fanny Robbesyn; Nathalie Augé; Cécile Vindis; Anne-Valérie Cantero; Ronald Barbaras; Anne Negre-Salvayre; Robert Salvayre
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-04-07       Impact factor: 8.311

Review 5.  Matrix metalloproteinases and coronary artery diseases.

Authors:  Uichi Ikeda; Kazuyuki Shimada
Journal:  Clin Cardiol       Date:  2003-02       Impact factor: 2.882

6.  Extracellular calcium (Ca2+o)-sensing receptor in a mouse monocyte-macrophage cell line (J774): potential mediator of the actions of Ca2+o on the function of J774 cells.

Authors:  T Yamaguchi; O Kifor; N Chattopadhyay; M Bai; E M Brown
Journal:  J Bone Miner Res       Date:  1998-09       Impact factor: 6.741

7.  Calcium receptor is functionally expressed in rat neonatal ventricular cardiomyocytes.

Authors:  Jacob Tfelt-Hansen; Jakob Lerche Hansen; Sanela Smajilovic; Ernest F Terwilliger; Stig Haunso; Soren P Sheikh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-10-21       Impact factor: 4.733

8.  Matrix metalloproteinase-2 expression by vascular smooth muscle cells is mediated by both stimulatory and inhibitory signals in response to growth factors.

Authors:  George M Risinger; Tamara S Hunt; Dawn L Updike; Elizabeth C Bullen; Eric W Howard
Journal:  J Biol Chem       Date:  2006-07-19       Impact factor: 5.157

9.  High glucose enhances MMP-2 production in adventitial fibroblasts via Akt1-dependent NF-kappaB pathway.

Authors:  Seung Jin Lee; Sun Sik Bae; Koan Hoi Kim; Won Suk Lee; Byung Yong Rhim; Ki Whan Hong; Chi Dae Kim
Journal:  FEBS Lett       Date:  2007-08-03       Impact factor: 4.124

10.  Bcl2 enhances c-Myc-mediated MMP-2 expression of vascular smooth muscle cells.

Authors:  Qun Lu; Wang Hong
Journal:  Cell Signal       Date:  2009-03-01       Impact factor: 4.315

View more
  17 in total

Review 1.  The role of oxysterols in vascular ageing.

Authors:  Simona Gargiulo; Paola Gamba; Gabriella Testa; Gabriella Leonarduzzi; Giuseppe Poli
Journal:  J Physiol       Date:  2016-01-19       Impact factor: 5.182

Review 2.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

3.  PI3K-Akt1 expression and its significance in liver tissues with chronic fluorosis.

Authors:  Bin Fan; Yanni Yu; Ying Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 4.  Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.

Authors:  Juanjuan Chen; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-22       Impact factor: 3.622

5.  Increased vascular and uteroplacental matrix metalloproteinase-1 and -7 levels and collagen type I deposition in hypertension in pregnancy: role of TNF-α.

Authors:  Wei Li; Ning Cui; Marc Q Mazzuca; Karina M Mata; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-16       Impact factor: 4.733

6.  oxLDL induces endothelial cell proliferation via Rho/ROCK/Akt/p27kip1 signaling: opposite effects of oxLDL and cholesterol loading.

Authors:  Chongxu Zhang; Crystal Adamos; Myung-Jin Oh; Jugajyoti Baruah; Manuela A A Ayee; Dolly Mehta; Kishore K Wary; Irena Levitan
Journal:  Am J Physiol Cell Physiol       Date:  2017-07-12       Impact factor: 4.249

7.  Astragaloside IV attenuates myocardial ischemia/reperfusion injury in rats via inhibition of calcium-sensing receptor-mediated apoptotic signaling pathways.

Authors:  Bo Yin; Xu-Wei Hou; Mei-Li Lu
Journal:  Acta Pharmacol Sin       Date:  2018-07-20       Impact factor: 6.150

8.  Decreased uterine vascularization and uterine arterial expansive remodeling with reduced matrix metalloproteinase-2 and -9 in hypertensive pregnancy.

Authors:  Chen Lin; Hong He; Ning Cui; Zongli Ren; Minglin Zhu; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-12-13       Impact factor: 4.733

9.  Molecular determinants of microvascular dysfunction in hypertensive pregnancy and preeclampsia.

Authors:  Wentao Yu; Wei Gao; Dan Rong; Zhixian Wu; Raouf A Khalil
Journal:  Microcirculation       Date:  2018-10-19       Impact factor: 2.628

10.  Altered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy.

Authors:  Wei Li; Karina M Mata; Marc Q Mazzuca; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2014-04-03       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.